Table of contents
March 2020 - Volume 58 - 3
Editorial
- Dapagliflozin for type 1 diabetes: ensuring benefits outweigh the risks (26 February, 2020)
DTB Select
- Are patient education materials for deprescribing fit for purpose? (12 February, 2020)
- Self-monitoring blood glucose in non-insulin type 2 diabetes (12 February, 2020)
- Community pharmacy interventions and health outcomes (26 February, 2020)
- Ursodeoxycholic acid offers no benefit in obstetric cholestasis (26 February, 2020)
Review
- Prescribing for pregnancy: asthma (26 February, 2020)
DTB commentary